Article

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece

2023-03-28

Abstract excerpt

<h4>Background</h4> In general, COVID-19 vaccines are safe and effective, but minor adverse effects are common. <h4>Objective</h4> To estimate the prevalence of adverse effects after the first COVID-19 booster dose, and to identify possible risk factors. <h4>Material and methods</h4> We conducted a cross-sectional study with a convenience sample in Greece during November 2022. We measured several adverse effects a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0c192b0d-f52d-5997-a665-beb271e360f9
DOI: 10.1101/2023.03.27.23287816

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from GreeceDOI 10.1101/2023.03.27.23287816Read

Prevalence and Risk Factors of CoronaVac Side Effects: An Independent Cross-Sectional Study Among Healthcare Workers in TurkeySemantic proximity Read

A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccinationSemantic proximity Read

Effect of psychological factors on COVID-19 vaccination side-effects : A survey study among the Korean populationSemantic proximity Read

An objective systematic comparison of the most common adverse events of COVID-19 vaccinesSemantic proximity Read

Incidence and Nature of Adverse Events Following COVID-19 Second Boosters: Insights from Taiwan's Universal Vaccination StrategySemantic proximity Read

Assessment of Safety and Acceptance toward Covid-19 Vaccines: A cross-sectional Study in EgyptSemantic proximity Read

Serious adverse events reported from the COVID-19 vaccines: A descriptive study based on WHO databaseSemantic proximity Read

Safety and Adverse Effects of the COVID-19 Vaccine Among the General Japanese PopulationSemantic proximity Read

Review on different COVID-19 vaccines approved for Emergency Use Listing by WHO until 11 July 2022: characterization, pharmacological properties, mechanism of action and adverse events.Semantic proximity Read

Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staffs with a history of allergySemantic proximity Read

Self-Reported Adverse Events Following SARS-CoV-2 Vaccination: A Nationwide Questionnaire Study in the Adult Danish PopulationSemantic proximity Read

mRNA-COVID19 vaccination can be considered safe and tolerable for frail patientsSemantic proximity Read